Gardnerella vaginalis
Gardnerella vaginalis is a Gram-variable bacteria species and the main causative agent of bacterial vaginosis, a common vaginal infection. It was first identified by the American bacteriologist Herman L. Gardner in 1955.
Taxonomy[edit]
Gardnerella vaginalis is a small, non-motile, non-spore-forming, facultative anaerobic bacteria. It is classified under the phylum Actinobacteria, class Actinobacteria, order Bifidobacteriales, and family Bifidobacteriaceae.
Morphology[edit]
The bacteria are pleomorphic, meaning they can change their shape or size in response to environmental conditions. They are typically rod-shaped but can also appear coccobacillary. They are Gram-variable, which means they do not consistently stain either positive or negative with Gram stain.
Pathogenesis[edit]
Gardnerella vaginalis is associated with bacterial vaginosis, a condition characterized by an overgrowth of certain bacteria in the vagina. The bacteria adhere to the vaginal epithelial cells, forming a biofilm that protects them from the immune system and antibiotics. They produce a variety of virulence factors, including cytolysins, sialidases, and proteases, which contribute to the symptoms of bacterial vaginosis.
Diagnosis and Treatment[edit]
Diagnosis of bacterial vaginosis typically involves a physical examination, a review of medical history, and laboratory tests. The presence of Gardnerella vaginalis can be confirmed through microscopy, culture, or polymerase chain reaction (PCR). Treatment usually involves antibiotics, such as metronidazole or clindamycin.
Epidemiology[edit]
Bacterial vaginosis is the most common vaginal infection in women of reproductive age. However, Gardnerella vaginalis can also be found in healthy women, suggesting that its presence alone is not sufficient to cause disease.
See also[edit]
References[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian